Dialysis: Muath Alismail Reviewed With: Dr. Munir
Dialysis: Muath Alismail Reviewed With: Dr. Munir
Dialysis: Muath Alismail Reviewed With: Dr. Munir
Muath Alismail
Reviewed with: Dr. Munir
Outlines
● Definitions
● Major modalities
● Indications
● Complications
Dialysis can normalize fluid balance, correct electrolyte and other solute
abnormalities, and remove uremic toxins or drugs from the circulation
when the patient’s kidneys are unable to do so
How it works?
Such bleeding can usually be stopped by applying firm pressure to the access site.
Stenosis or thrombosis presents with loss of bruit and thrill over the access.
-Redness, hotness, and tenderness over the site often are obvious, but in many cases localizing findings
are absent, and the patient has only fever or a history of recurrent episodes of fever and documented
bacteremia.
- IV vancomycin, 1 to 1.5 g, given as a single loading dose, is the drug of choice in this case because most
access infections are staphylococcal and because this drug is only minimally hemodialyzable and needs to
be given only every 5 to 7 days in the chronic dialysis patient. If a gram- negative infection also is thought
to be likely, as in a patient who has had recent episodes of gram-negative bacteremia, a loading dose of a
second drug (eg, a third-generation cephalosporin or aminoglycoside) also can be administered. Patients
can be reloaded with these drugs at the end of their next hemodialysis session if culture results prove to
be positive.
Serum levels of clotting factors are normal in CKD, but patients are routinely anticoagulated for
each hemodialysis treatment and, although transient thrombocytopenia may occur during the
dialysis procedure, the qualitative platelet defect characteristic of renal failure is an important
factor in bleeding that continues beyond the peridialytic period. This abnormality is only partially
reversed by dialysis but can be corrected by the administration of desmopressin (DDAVP), which
increases the release of factor VIII–von Willebrand factor polymers from vascular endothelium.
Cryoprecipitate and conjugated estrogen both have been shown to produce similar effects for a
longer period.
Cardiovascular disease is a leading cause of death in patients with CKD, and most
episodes of chest pain occurring during dialysis are likely to be ischemic in origin.
Most dialysis patients have risk factors for coronary artery disease, related to CKD
itself or the underlying condition that led to renal failure, and many have well
documented coronary artery disease.
It usually occurs only in patients with high BUN levels who are just starting
hemodialysis; the syndrome does not occur with peritoneal dialysis.
Typically, patients have headache, malaise, nausea, vomiting, and muscle cramps
but, in more severe cases, features may include altered mental status, seizures, or
coma. Symptoms resolve over several hours as fluid and solutes are redistributed
across cell membranes.
(B) Hyperphosphatemia
(C) Hypocalcemia
(D) Hypoglycemia
(E) Hypotension
The answer is (E) Hypotension occurs in up to 30% of hemodialysis treatments,
usually caused by excessive ultrafiltration after underestimating the patient’s ideal
(dry) weight. Other complications that occur less frequently include air
embolism,cerebral edema from dialysis disequilibrium, hemorrhage from accessing
the vascular access site, hypercalcemia, hypermagnesemia, and hypoglycemia.
Peritonitis
• The most common problems with vascular access devices used for hemodialysis are thrombosis, hemorrhage,
and infection.
• Peritoneal dialysis associated peritonitis typically presents with cloudiness of the peritoneal dialysis. The
diagnosis is made by a positive Gram stain or finding of more than 100 WBC/mm3 , with at least 50% polys.
• Chest pain in the dialysis patient should be presumed initially to be due to acute coronary syndrome, although
other potentially serious causes may also be responsible.
• Hypotension in CKD patients is often caused by infection, but may also be the result of rapid fluid removal
during dialysis.
• Altered mental status is most commonly due to causes similar to patients without renal disease, but is
sometimes the result of overrapid shifts in intravascular fluid and solutes during dialysis, termed disequilibrium
syndrome.
References